GE Healthcare Opens Startup Labs at Former AstraZeneca UK R&D Site
Xconomy
NOVEMBER 6, 2019
The AstraZeneca (NYSE: AZN ) site in Macclesfield, UK, housed 3,500 staff and was instrumental in developing a number of its cancer drugs including tamoxifen (Nolvadex), goserelin (Zoladex), bicalutamide (Casodex), anastrozole (Arimidex), and gefitinib (Iressa).
Let's personalize your content